Clarkson C W, Hondeghem L M
Circ Res. 1985 Apr;56(4):496-506. doi: 10.1161/01.res.56.4.496.
According to the modulated receptor hypothesis, sodium channels have a specific receptor site for local anesthetic and antiarrhythmic drugs. Thus, in the presence of a high concentration of two drugs, competitive displacement of one drug by another may occur. Furthermore, if a drug that has relatively rapid post-stimulation recovery kinetics (e.g., lidocaine) displaces another drug with relatively slow recovery kinetics (i.e., quinidine or bupivacaine), then a net reduction in sodium channel blockade is expected at certain stimulation rates. We tested this prediction, using the maximum upstroke velocity of the ventricular action potential as an indicator of drug-free sodium channels. A single sucrose gap technique was used to stimulate guinea pig papillary muscles, and to control membrane voltage at all times except during the action potential upstroke. Drug-induced inhibition of maximum upstroke velocity increased as the stimulation rate was increased, and was significant (P less than 0.05) at stimulation rates between 2.5 and 4 Hz in the presence of 43 microM lidocaine (n = 5), and between 0.15 and 4 Hz in the presence of 3.5 microM bupivacaine (n = 4). The addition of 43 microM lidocaine to a perfusate containing 3.5 microM bupivacaine resulted in a net increase in maximum upstroke velocity that was significant at rates between 1 and 3.3 Hz, with a maximum increase of 25 +/- 6% at 1.6 Hz. In contrast, addition of 43 microM lidocaine to a perfusate containing 15 microM quinidine did not result in a significant change in maximum upstroke velocity at driving rates between 0.05 and 3.3 Hz (P greater than 0.2; n = 4). However, evidence for displacement of quinidine by lidocaine could be demonstrated by measuring post-stimulation recovery after a conditioning train of 19 10-msec pulses applied at 28 Hz. With this stimulation protocol, 41 +/- 4% of maximum upstroke velocity recovered slowly from block with a time constant of 3.7 +/- 1.2 seconds at - 100 mV in the presence of 15 microM quinidine (n = 5). In the presence of a mixture of 43 microM lidocaine and 15 microM quinidine, this slow component was significantly reduced to 16 +/- 7% (n = 5; P less than 0.01), while 71 +/- 13% of maximum upstroke velocity recovered with a time constant of 115 +/- 21 msec, typical of lidocaine-blocked channels. A two-drug version of the modulated receptor theory was formulated. The effects of drug mixtures could be accounted for by this model.(ABSTRACT TRUNCATED AT 400 WORDS)
根据调制受体假说,钠通道具有针对局部麻醉药和抗心律失常药物的特定受体位点。因此,在两种药物浓度较高的情况下,一种药物可能会被另一种药物竞争性取代。此外,如果一种具有相对快速的刺激后恢复动力学的药物(如利多卡因)取代了另一种具有相对缓慢恢复动力学的药物(即奎尼丁或布比卡因),那么在特定刺激频率下,钠通道阻滞有望净减少。我们以心室动作电位的最大上升速度作为无药物钠通道的指标来检验这一预测。采用单蔗糖间隙技术刺激豚鼠乳头肌,并在动作电位上升期之外的所有时间控制膜电压。药物诱导的最大上升速度抑制随刺激频率增加而增加,在43微摩尔/升利多卡因存在时(n = 5),刺激频率在2.5至4赫兹之间,以及在3.5微摩尔/升布比卡因存在时(n = 4),刺激频率在0.15至4赫兹之间,这种抑制具有显著性(P小于0.05)。向含有3.5微摩尔/升布比卡因的灌注液中添加43微摩尔/升利多卡因,导致最大上升速度净增加,在1至3.3赫兹之间具有显著性,在1.6赫兹时最大增加25±6%。相比之下,向含有15微摩尔/升奎尼丁的灌注液中添加43微摩尔/升利多卡因,在驱动频率0.05至3.3赫兹之间,最大上升速度没有显著变化(P大于0.2;n = 4)。然而,通过测量在28赫兹施加19个10毫秒脉冲的条件刺激序列后的刺激后恢复情况,可以证明利多卡因对奎尼丁的取代作用。采用这种刺激方案,在15微摩尔/升奎尼丁存在时(n = 5),最大上升速度的41±4%从阻滞中缓慢恢复,在-100毫伏时时间常数为3.7±1.2秒。在43微摩尔/升利多卡因和15微摩尔/升奎尼丁的混合物存在时,这种缓慢成分显著降低至16±7%(n = 5;P小于0.01),而最大上升速度的71±13%以115±21毫秒的时间常数恢复,这是利多卡因阻滞通道的典型情况。提出了调制受体理论的双药版本。该模型可以解释药物混合物的作用。(摘要截取自400字)